Debate rages over use of fresh stem cell eggs
By Shin Sung-Sik, Kang Ki-Heon, and Esther Chung,
Joongang Daily [South Korea]
| 05. 20. 2016
The use of fresh egg cells in stem cell research, banned in Korea for years, is being hotly debated by the Ministry of Health and Welfare and the Ministry of Science, ICT and Future Planning.
The Bioethics and Safety Act forbids the use of fresh egg cells in stem cell research, more specifically in the process of somatic cell nuclear transfer (SCNT), which can be used to create clones for reproductive and therapeutic purposes by removing the nucleus of an egg cell and replacing it with the nucleus of a somatic cell.
The Ministry of Science, ICT and Future Planning is asking for a policy revision whereby the use of fresh egg cells, voluntarily donated, would be allowed for further development in stem cell research.
The use of fresh eggs in SCNT was made illegal in Korea after 2005, when Hwang Woo-suk, a veterinarian and a former professor at Seoul National University, was found to have fabricated evidence and even bought human eggs for his stem-cell research, which was once regarded as a breakthrough in the science of cloning.
Hwang...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
